STRYKER CORP Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High
STRYKER CORP (SYK) had Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High of $1 as of 2017-03-31, per its 10-Q filed 2017-04-27.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Contingent Consideration
us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh · last filed 2017-04-27
- 2017-03-31: Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $1.00.
- 2016-12-31: Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $1.00.
- 2014-12-31: Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $0.00.
| Period end | Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High |
|---|---|
| 2017-03-31 | $1.00 10-Q · filed 2017-04-27 |
| 2016-12-31 | $1.00 10-K · filed 2017-02-09 |
| 2014-12-31 | $0.00 10-K · filed 2015-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |